Tenaya Therapeutics (TNYA)
(Delayed Data from NSDQ)
$0.67 USD
+0.01 (0.86%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.66 -0.01 (-1.33%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Tenaya Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TNYA 0.67 +0.01(0.86%)
Will TNYA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TNYA based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for TNYA
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference | ...
TNYA: Chardan Capital Maintains Buy Rating with Price Target of $9.00 | TNYA Stock News
Tenaya Therapeutics GAAP EPS of -$0.14 beats by $0.06
Tenaya Therapeutics reports Q2 EPS (14c), consensus (19c)
Tenaya Therapeutics Inc Reports Q2 2025 EPS of -$0.14, Beating Estimates; Net Loss at $23.3 Million